Vacuum level did not have a significant effect on total US energy or total fluid consumed during phacoemulsification. There was a strong relationship between total US energy and endothelial cell loss but not between total infused fluid and endothelial cell loss.
Dissection plane in DALK using the big-bubble technique can be within corneal stroma rather than exactly between stroma and DM. Various corneal pathologies as well as different techniques of dissection may have influence on this level.
Given systemic problems in patients with MLS and less postoperative complications of DALK in comparison with penetrating keratoplasty, it seems DALK is the better choice for these patients.
The finding of R124H in the Middle Eastern (Iranian) population supports the proposal that perhaps only substitution of histidine for arginine at position 124 of tumour growth factor beta induced protein results in the Avellino corneal dystrophy phenotype. As both probands were originally diagnosed with granular corneal dystrophy, and as heterozygous carriers of R124H were unaware of their disease status prior to genetic analysis, the importance of genetic analysis is emphasized.
PURPOSE: To evaluate the efficacy, predictability, stability, and safety of laser in situ keratomileusis (LASIK) to correct residual astigmatism after cataract surgery. METHODS: LASIK was performed on 20 eyes of 20 patients with refractive myopic or mixed astigmatism (3.00 to 6.00 D) at least 1 year after extracapsular cataract extraction with posterior chamber intraocular lens implantation without complication. Each eye received bitoric LASIK with the Nidek EC-5000 excimer laser and the Automated Corneal Shaper microkeratome. RESULTS: At 6 months after LASIK, mean refractive cylinder decreased from 4.64*0.63 D to 0.44±0.24 D (P<.001). Mean percent reduction of astigmatism was 90.4*5.0% (range 80% to 100%). Mean spherical equivalent refraction decreased from -2.19±0.88 D (range -1.00 to -3.88 D) to -0.32±0.34 D (range -1.25 to +0.38 D) (P<.001). Vector analysis showed that the mean amount of axis deviation was 0.7±1.2° (range 0° to 4.3°) and the mean percent correction of preoperative astigmatism was 92.1*5.9% (range 85.6% to 108%). Eighty-five percent of all eyes had a mean spherical equivalent refraction and mean cylinder within ±0.50 D of emmetropia. Change in spherical equivalent refraction and cylinder from 2 weeks to 6 months was =S0.50 D in 90% (18 eyes) and 95% (19 eyes), respectively. Spectacle-corrected visual acuity was not reduced in any eye. Diffuse lamellar keratitis occurred in three eyes (15%) after LASIK, and were treated successfully with eyedrops. CONCLUSION: LASIK was an effective, predictable, stable, and safe procedure for correction of residual myopic or mixed astigmatism ranging from 3.00 to 6.00 D with a low spherical component after cataract surgery. [J Refract Surg 2003;19: 416-424]
ber depth measurement with a-scan ultrasonography, Orbscan II, and IOLMaster. Optom Vis Sci 2005; 82:900-904 Relationship between hydrodynamic parameters and endothelial cell loss after phacoemulsificationThe article by sets out to determine whether any relationship exists between fluid usage and/or phaco power expended during cataract surgery and subsequent endothelial cell loss. Two sets of fluidics parameters are compared; one is low flow (20 cc/min) and low vacuum (200 mm Hg), the other high flow (40 cc/min) and high vacuum (400 mm Hg). The same ultrasound (US) power settings are used in both groups.First, there is a glaring proofreading error on the part of the authors and reviewers (eg, US power modulations quoted for the AMO Sovereign [Abbott Medical Optics, Inc.] were in seconds of on and off time, not milliseconds). What is more concerning, however, is the basic lack of understanding of how changes in phacodynamic parameters will influence phacoemulsification. In the final paragraph it is stated, ''For example, choosing a low flow rate with high vacuum might induce a surge phenomenon in the anterior chamber, which could cause more endothelial cell loss by making mechanical changes in corneal shape. That is why we increased the flow rate from 20.0 to 40.0 cc at the chop stage in the high-vacuum group to preserve the integrity of the anterior chamber.'' The opposite is of course true; a higher aspiration flow rate will lead to a less stable anterior chamber at occlusion break, particularly here, where a fixed flow rate is used.In the discussion section, it is noted that there appears to be a higher mean power usage in the high vacuum group than in the low-vacuum group and stated that this might be due to ''.the longer chop stage in the low-vacuum group. Low-vacuum status reduces nuclear engagement in the phaco tip, which indirectly prolongs total phaco time. High-vacuum status increases nuclear engagement in the phaco tip, which indirectly shortens total phaco time.'' What is not clear is whether total phaco time is the time spent in foot position 3 or the time taken to remove the nucleus. One would expect that less power would be used when chopping with high vacuum and flow as the pieces are held more firmly and can be drawn through the phaco needle with less energy. It is unfortunate that the energy used and the time taken for the separate sculpt and chop stages were not recorded. These data are available in the printout from the Sovereign machine.In the same paragraph, it is stated that there was no significant difference in the dissipated energy between the 2 groups but then stated ''[w]e found total US energy to be a significant risk factor in corneal endothelial cell loss.'' This is presumably because a similar amount of fluid was used in both groups and it was thought that this alone would exclude it from blame. However, the same amount of fluid was used but for different times. The phaco time was 50% longer in the low-vacuum group than in the high-vacuum group. One might infer from this that b...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.